SN7
SHORT NOTE
5M
Describe the coronaviruses and the other emerging viral infections.
Coronaviruses
- Enveloped viruses with a helical nucleocapsid and the largest genome of any RNA virus — single-stranded positive-sense RNA. The name comes from the crown-like fringe of spike (S) glycoprotein seen on electron microscopy
- The spike protein determines the receptor and is the vaccine target; SARS-CoV-1 and SARS-CoV-2 bind ACE2, and MERS-CoV binds DPP4
- Unusually for an RNA virus it has a proofreading exonuclease, so it mutates more slowly than influenza or HIV — though over a pandemic of that scale variants still emerged
| Virus | Emergence and reservoir | Features |
|---|---|---|
| Common cold coronaviruses | Endemic worldwide | Mild upper respiratory illness; a significant proportion of common colds |
| SARS-CoV-1 | 2002, China; bats through civet cats | Severe acute respiratory syndrome; high mortality but contained and eliminated by isolation and contact tracing, because patients were infectious only after becoming symptomatic |
| MERS-CoV | 2012, Arabian peninsula; bats through dromedary CAMELS | High mortality (about 35%) but limited person-to-person spread; nosocomial outbreaks |
| SARS-CoV-2 | 2019; probable bat origin | COVID-19 — a pandemic, driven by substantial pre-symptomatic and asymptomatic transmission, which is precisely why it could not be contained as SARS-CoV-1 was |
CLINICAL PEARL
SARS was contained and COVID-19 was not, and the difference was the timing of infectivity. SARS-CoV-1 patients became infectious after they were symptomatic, so isolating symptomatic people interrupted transmission. SARS-CoV-2 spreads before symptoms and from people who never develop them, so the same strategy failed. A single feature of natural history, not virulence or transmissibility alone, determined whether an outbreak could be stopped by classical public health methods.
Covid-19 — Key Points
- Transmission — respiratory droplets and aerosols, favoured by crowded, closed and poorly ventilated spaces; and by contaminated surfaces to a lesser extent
- Clinical spectrum — from asymptomatic through mild upper respiratory illness to pneumonia, acute respiratory distress syndrome, thrombosis and multi-organ failure. anosmia and ageusia were characteristic early features; "happy hypoxia", with marked hypoxaemia and little breathlessness, was a notable and dangerous presentation
- Risk factors for severe disease — age, obesity, diabetes, hypertension, chronic lung, cardiac and kidney disease, and immunosuppression
- Diagnosis — RT-PCR on a nasopharyngeal swab is the standard; rapid antigen tests are less sensitive but useful for rapid screening; serology indicates past infection or vaccination
- Treatment — supportive care and oxygen; dexamethasone in those requiring oxygen (its mortality benefit was among the most important findings of the pandemic); anticoagulation; and antivirals in selected patients. Antibiotics have no role unless bacterial co-infection is proven
- Vaccines — developed with unprecedented speed using mRNA, viral vector and inactivated whole-virus platforms; India produced and deployed Covishield and the indigenous Covaxin on a very large scale
- Long COVID — persistent fatigue, breathlessness, cognitive difficulty and other symptoms lasting months, of uncertain mechanism
Other Emerging Viral Infections
| Virus | Reservoir and transmission | Features |
|---|---|---|
| NIPAH | Fruit bats; through date palm sap, pigs, and person TO person | Outbreaks in KERALA and West Bengal; encephalitis with respiratory illness and very high mortality; requires BSL-4 handling and strict barrier nursing |
| EBOLA and Marburg | Bats; person to person through body fluids | Viral haemorrhagic fever with high mortality; healthcare workers and those handling bodies are at particular risk; an effective vaccine now exists |
| ZIKA | AEDES mosquitoes; also sexual and vertical transmission | A mild illness in adults, but causes microcephaly and congenital Zika syndrome, and Guillain-Barré syndrome |
| Crimean-Congo haemorrhagic fever | Ticks and livestock; person to person including to healthcare workers | Reported from Gujarat and Rajasthan; high mortality |
| Kyasanur Forest disease | Ticks; monkeys; Western Ghats | Haemorrhagic fever with a biphasic course; a vaccine exists |
| Hantavirus | Rodent excreta | Haemorrhagic fever with renal syndrome; pulmonary syndrome |
Applied Aspects
- Most emerging viruses are zoonoses, and their emergence is driven by deforestation, wildlife trade, intensive animal farming, urbanisation and travel — so prevention is ecological and agricultural as much as medical
- The "one health" approach — integrating human, animal and environmental health surveillance — is the accepted framework, and India has established programmes along these lines
- Suspect Nipah in encephalitis with respiratory features in Kerala, particularly with bat or date palm sap exposure or a cluster of cases, and institute barrier precautions immediately; healthcare workers have died in Indian outbreaks
- Barrier precautions protect staff in viral haemorrhagic fevers; nosocomial amplification has been a feature of nearly every outbreak, and safe burial practices matter as much as clinical care
- Rapid genomic sequencing and open data sharing allowed the SARS-CoV-2 vaccine to be designed within days of the sequence being published, and this capacity is now part of outbreak preparedness
- Notify unusual clusters early; the interval between the first case and recognition determines whether an outbreak is contained or becomes an epidemic, and that interval depends on a clinician thinking something is odd and reporting it
All questions in RNA Viruses & HIV
- Q1Describe influenza virus with its structure, antigenic variation, complications and prevention. ★
- Q2Describe poliovirus and the other enteroviruses. Compare the two polio vaccines and discuss eradication. ★
- Q3Describe HIV with its structure, replication, transmission, natural history and laboratory diagnosis. ★
- Q4Classify the arboviruses. Describe dengue, chikungunya and Japanese encephalitis with vector control. ★
- Q5Describe rabies virus with its pathogenesis, clinical features and post-exposure prophylaxis. ★
- SN1Describe measles with its clinical features, complications and prevention. ★
- SN2Describe rubella and the congenital rubella syndrome with its diagnosis and prevention. ★
- SN3Describe mumps with its clinical features, complications and prevention. ★
- SN4Describe rotavirus and the other viral causes of gastroenteritis with their management. ★
- SN5Describe hepatitis A and hepatitis E with their epidemiology, course and prevention. ★
- SN6Describe hepatitis C with its natural history, diagnosis and treatment. ★
- SN7Describe the coronaviruses and the other emerging viral infections.